Can insulin resistance occur in a lean man?
Yes — insulin resistance can affect men with a normal BMI too, if fat accumulates mainly viscerally and inside internal organs rather than under the skin. We explain the TOFI phenomenon (thin-outside-fat-inside) and why BMI alone isn't enough to assess metabolic risk.
Number of studies
1
Safety
Requires caution
Time to effects
Not applicable — this is an interpretive question, not an intervention.
Who it's for
Table of contents
TL;DR
Yes — insulin resistance can affect men with a normal BMI too, if fat accumulates mainly viscerally and inside internal organs rather than under the skin. We explain the TOFI phenomenon (thin-outside-fat-inside) and why BMI alone isn't enough to assess metabolic risk.
- →Helps avoid dismissing suspected insulin resistance just because BMI is normal
- →Points to waist circumference and body composition as better screening tools for men than weight alone
- →Supports early lifestyle changes before overt type 2 diabetes develops
| Type of question | Interpreting metabolic risk when BMI is normal |
|---|---|
| Level of evidence | Moderate — the phenomenon is well described, though diagnostic criteria are less standardized than for classic obesity |
| Who it affects | Lean men whose fat accumulates mainly around the abdomen (apple shape) |
| Key mechanism | Visceral and ectopic fat (liver, pancreas, muscle) despite normal body weight |
| What to do next | Waist circumference, HOMA-IR, lipid panel (triglycerides/HDL), liver assessment if fatty liver is suspected |
| Status | A normal BMI does not rule out insulin resistance |
Understand
Overview
Yes, insulin resistance can occur in a man with a normal body weight and a normal BMI. This is described in the literature by the acronym TOFI (thin-outside-fat-inside) — lean-looking on the outside, but carrying an excess of fat hidden inside the abdominal cavity. BMI only measures the ratio of body weight to height and says nothing about where in the body fat accumulates — and it's this distribution, far more than the total amount, that drives metabolic risk.
Men naturally tend toward an android (abdominal) fat distribution pattern, which includes not only subcutaneous belly fat but also visceral fat surrounding internal organs and ectopic fat deposited in the liver, pancreas, and skeletal muscle. In some lean men, the storage capacity of subcutaneous fat tissue is limited — genetically, or due to low physical activity combined with an unfavorable diet — so surplus energy ends up in these locations instead, even though total body weight and BMI remain normal. This concept was first systematically described by Ruderman and colleagues in 1981, who coined the term 'metabolically obese, normal-weight' (MONW) for people with a normal weight but a metabolic profile typical of obesity.
This partly explains why the phenomenon is described more often in men than in premenopausal women — women at this life stage have a physiological tendency toward a gynoid distribution (hips, thighs), which carries lower metabolic risk than an android distribution even at the same total amount of body fat. That's why a man with a normal BMI but a waist circumference above 94 cm may genuinely carry a higher insulin resistance risk than his weight alone would suggest.
In practice, this means insulin resistance shouldn't automatically be ruled out in a lean man just because he weighs a normal amount. Indications for further work-up include: a waist circumference disproportionately large for his frame, a family history of type 2 diabetes, elevated triglycerides with low HDL (the triglyceride-to-HDL ratio as an indirect insulin resistance marker), and signs of fatty liver on imaging or elevated liver enzymes without significant alcohol use. In these situations, it's worth measuring fasting glucose and insulin and calculating the HOMA-IR index, rather than basing the risk assessment on BMI alone.
If you suspect this scenario applies to you, the full picture of the mechanism, diagnosis, and management of insulin resistance is covered in our general insulin resistance entry, and the details on visceral fat specifically are covered in our dedicated visceral fat entry. This piece deliberately focuses only on the question of whether a lean physique rules out the problem — and the answer is: no.
Mechanism of action
The TOFI phenomenon is explained by the so-called lipid overflow hypothesis: when subcutaneous fat tissue's capacity to safely store surplus energy as fat is limited, the excess fatty acids end up in locations that aren't physiologically designed for it — the liver, pancreas, skeletal muscle, and the visceral space around abdominal organs. This accumulation of fat in these sites (ectopic fat) leads to lipotoxicity — an excess of intracellular lipids disrupts the insulin receptor's signaling cascade in hepatocytes and myocytes, even though total body fat and BMI remain normal.
Fat distribution also has a hormonal basis that differs by sex: androgens favor an android fat distribution, typical of men, while estrogens favor a gynoid distribution, which is metabolically more favorable. This is one reason the 'thin-outside-fat-inside' phenomenon is disproportionately described in men, and in postmenopausal women, when estrogen's protective effect on fat distribution weakens.
Limited subcutaneous fat storage capacity
When subcutaneous fat storage capacity is limited, the body has nowhere safe to store surplus energy.
Lipid overflow to the liver, pancreas, and muscle
Excess fatty acids end up ectopically in internal organs and skeletal muscle, despite a normal total body weight.
Impaired insulin signaling despite normal BMI
Lipotoxicity at these sites disrupts insulin action at the cellular level regardless of what the scale shows.
Evidence: moderate — based on 1 study in this database.
Benefits
Common myths
MythA normal BMI rules out insulin resistance.
FactBMI doesn't assess fat distribution — a normal-weight man can carry a significant amount of visceral and ectopic fat, enough to drive insulin resistance.
MythInsulin resistance only affects people with visible excess weight.
FactThe TOFI phenomenon (thin-outside-fat-inside) shows that insulin resistance can develop in people who look lean if fat accumulates mainly inside the abdominal cavity and organs.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
Yes. What matters most is fat distribution, not body weight alone — excess visceral and ectopic fat (liver, pancreas, muscle) can drive insulin resistance despite a normal BMI.
The simplest screening measure is waist circumference — above 94 cm in men, metabolic risk rises regardless of BMI. A fuller picture comes from a lipid panel and a HOMA-IR index calculated from fasting glucose and insulin.
Yes — visceral fat can be reduced even without significant weight loss, through regular physical activity, cutting back on alcohol and fructose, and improving diet quality.
Less often before menopause, since estrogens favor a more metabolically favorable gynoid fat distribution. After menopause, as their influence weakens, the risk of an android distribution and associated insulin resistance rises in women too.
What to combine with
Good combinations
Insulin Resistance — The full picture of the mechanism, diagnosis, and management of insulin resistance as a condition — this entry only answers the narrow question about a lean physique.
Visceral Fat — Details on why visceral fat is metabolically more harmful than subcutaneous fat and how to assess it.
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Interactions
A family history of type 2 diabetes raises risk independent of current body weight
Low physical activity alongside a seemingly normal diet can mask the gradual buildup of visceral fat
Alcohol intake and excess fructose promote fat accumulation in the liver independent of BMI
Ethnic predisposition (e.g., South Asian populations) is linked to a greater tendency toward visceral fat at a lower BMI than in European populations
Is it worth taking?
Who it's for
- Lean men whose fat accumulates mainly around the abdomen
- People with a family history of type 2 diabetes despite a normal weight
- Men with an abnormal lipid panel or signs of fatty liver despite a normal BMI
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
The term 'metabolically obese, normal-weight' (MONW) was introduced by Ruderman and colleagues as early as 1981.
A waist circumference above 94 cm in men is linked to elevated metabolic risk regardless of BMI.
The triglyceride-to-HDL ratio is sometimes used as a simple, indirect marker of insulin resistance when a full HOMA-IR isn't available.
Studies
People with a normal body weight can present a metabolic profile typical of obesity — hyperinsulinemia and insulin resistance — despite the absence of excess weight as measured by BMI.
based on: Ruderman NB et al., American Journal of Clinical Nutrition, 1981
The 'metabolically-obese,' normal-weight individual
Moderate evidenceRuderman NB, Schneider SH, Berchtold P · American Journal of Clinical Nutrition · 1981
The paper introducing the concept of metabolically obese, normal-weight individuals (MONW) — describing a profile of hyperinsulinemia and insulin resistance in people without excess weight as measured by BMI.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Piotr ZielińskiEndocrinologist
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
235 publications on this site
Medical review
Michał NowakClinical Dietitian
Michał started out as a long-distance runner, before an injury forced him to rethink his career. Looking for a faster way back into shape, he discovered sports nutrition and never left — fascinated by the gap between the research and what "everyone knows" at the gym. He completed a degree in clinical dietetics, earned a sports-nutrition coaching certification, and ran his own practice for several years before joining VitMode. His writing keeps returning to one theme: a supplement won't replace the basics, but the right one, at the right time, makes a real difference — and that's the difference he tries to describe precisely, with citations instead of slogans. He still runs, though these days, as he puts it, purely for the fun of it.
137 publications on this site
Related entries
4.6Insulin Resistance
A state in which the body's cells respond more weakly to insulin, forcing the pancreas to produce ever-larger amounts of it — the most common, and largely reversible, precursor of type 2 diabetes.
4.6Visceral Fat
Fat tissue that accumulates around the internal organs of the abdominal cavity is metabolically far more active and harmful than subcutaneous fat — even though the two can look similar from the outside.
4.7HbA1c (Glycated Hemoglobin)
A biomarker reflecting average blood glucose over the past 2–3 months — the gold standard for diagnosing and monitoring diabetes, far more stable than a single glucose measurement.
4.6Insulin
A key anabolic hormone regulating blood glucose levels — understanding how it works is the foundation of consciously managing metabolic health, regardless of whether someone has diabetes.
4.7Why is insulin high despite normal glucose?
Elevated insulin with normal fasting glucose is most often compensatory hyperinsulinemia — the pancreas produces more insulin to keep glucose normal despite the tissues' weaker response. It's an early warning sign that the HOMA-IR index can catch long before glucose itself ever rises.
4.6Can high insulin lower SHBG?
Yes — insulin directly suppresses SHBG production in the liver, making chronically elevated insulin one of the best-documented causes of low SHBG. This is an important bridge between insulin resistance and the interpretation of testosterone results.
4.5Can insulin resistance occur without being overweight?
Yes — insulin resistance can occur even in people with no excess body fat at all, including visceral fat. We explain the rarer, but real, mechanisms that operate independently of fat: genetic variants in the insulin signaling pathway, chronic sleep deprivation, and chronic stress.
Related articles
PoradnikiWalking After Meals: How Much Does It Really Lower the Post-Meal Blood Sugar Spike?
"Be active" is advice so general it barely tells you when exactly to move. A randomized clinical trial in people with type 2 diabetes found something far more specific: a short walk right after a meal lowers the post-meal glucose spike more effectively than a generic recommendation to "meet your daily activity target" without specifying timing. What's more, the effect wasn't the same across all meals — after dinner specifically, walking cut the glucose spike by roughly 22%, considerably more than after other meals of the day. This suggests that for blood sugar control, what matters isn't just how much you move over 24 hours, but precisely when you do it. In this article we break down these findings step by step and explain exactly which population they've been shown in.
August 24, 2026
PoradnikiHow to Improve Insulin Sensitivity? 10 Ways Backed by Research
Insulin resistance rarely gives clear symptoms before it progresses into prediabetes or type 2 diabetes — and the internet is full of advice like "drink apple cider vinegar and eat cinnamon and your blood sugar will sort itself out." Some of that advice has real, if modest, research support; other parts are single, overhyped findings. We gathered ten ways to improve insulin sensitivity with genuine scientific documentation, clearly separating what's strongly proven from what's still promising but preliminary.
September 7, 2026
Poradniki5 Biomarkers Worth Knowing Before 40 — Signals Before Symptoms Appear
A standard "once-a-year blood count" often misses early signs of metabolic and hormonal issues. Here are five markers worth asking your doctor about, before anything starts to hurt.
August 1, 2026
PoradnikiTRT and Weight Loss — Does Testosterone Therapy Actually Help You Lose Weight?
Testosterone replacement therapy genuinely changes body composition in men with hypogonadism — less fat, more muscle — but it isn't a weight-loss drug, and the number on the scale after TRT often barely changes.
August 15, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.